Dexlansoprazole
These highlights do not include all the information needed to use DEXLANSOPRAZOLE DELAYED-RELEASE CAPSULES safely and effectively. See full prescribing information for DEXLANSOPRAZOLE DELAYED-RELEASE CAPSULES. DEXLANSOPRAZOLE delayed-release capsules, for oral use Initial U.S. Approval: 1995 (lansoprazole)
8dca4887-c75a-4021-8564-b704e9e1fa3e
HUMAN PRESCRIPTION DRUG LABEL
Jul 28, 2023
TWI PHARMACEUTICALS, INC.
DUNS: 658402052
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
dexlansoprazole
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (20)
dexlansoprazole
Product Details
FDA regulatory identification and product classification information